Market Research Logo

Global Peripheral Neuropathy Treatment Market 2018-2022

Global Peripheral Neuropathy Treatment Market 2018-2022

About Peripheral Neuropathy

Peripheral neuropathy is a set of symptoms caused by any damage to the nerves that are away from the brain and spinal cord. Peripheral neuropathy is not a single, homogenous disease, but it is a mix of different clinical presentations, natural histories, and pathology.

Technavio’s analysts forecast the Global Peripheral Neuropathy Treatment Market to grow at a CAGR of 3.5% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the peripheral neuropathy treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of peripheral neuropathy across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, peripheral neuropathy treatment market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Eli Lilly
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • TEVA Pharmaceutical Industries
Market driver
  • Growing awareness about peripheral neuropathy
  • For a full, detailed list, view our report
Market challenge
  • Complications involved in the diagnosis of peripheral neuropathy
  • For a full, detailed list, view our report
Market trend
  • Development of topical patches for neuropathy treatment
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global Peripheral Neuropathy Treatment Market 2018-2022

Technavio recognizes the following companies as the key players in the global peripheral neuropathy treatment market: Eli Lilly, Johnson & Johnson, Novartis, Pfizer, and TEVA Pharmaceutical Industries.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the development of topical patches for neuropathy treatment. Most of the established companies in the global peripheral neurotherapy treatment market are focused on getting involved in the development of topical patches.”

According to the report, one driver influencing this market is the growing awareness about peripheral neuropathy. The growth of the global neurotrophic keratitis market is driven by growing geriatric population which will boost the demand for various types of keratopathy treatment.

Further, the report states that one challenge affecting this market is the complications involved in the diagnosis of peripheral neuropathy. The diagnosis of peripheral neuropathy is very complicated and physicians face challenges due to the heterogenicity of the disease.

Companies Mentioned

Eli Lilly
Johnson & Johnson
Novartis
Pfizer
TEVA Pharmaceutical Industries

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global neuropathy pain treatment market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global peripheral neuropathy treatment market - Market size and forecast 2017-2022 ($ mn)
      • Table Global peripheral neuropathy treatment market - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Pipeline landscape
    • Table Pipeline landscape by development phase 2017-2018
    • Table Key clinical trials 2017-2018
  • Market segmentation by subtype
    • Segmentation by subtype
      • Table Global peripheral neuropathy treatment market by subtype - Market share 2017-2022 (%)
    • Comparison by subtype
      • Table Comparison by subtype
    • Diabetic peripheral neuropathy - Market size and forecast 2017-2022
      • Table Diabetic peripheral neuropathy - Market size and forecast 2017-2022 ($ mn)
      • Table Diabetic peripheral neuropathy - Year-over-year growth 2018-2022 (%)
    • Chemotherapy-induced peripheral neuropathy - Market size and forecast 2017-2022
      • Table Chemotherapy-induced peripheral neuropathy - Market size and forecast 2017-2022 ($ mn)
      • Table Chemotherapy-induced peripheral neuropathy - Year-over-year growth 2018-2022 (%)
    • Others - Market size and forecast 2017-2022
      • Table Others - Market size and forecast 2017-2022 ($ mn)
      • Table Others - Year-over-year growth 2018-2022 (%)
    • Market opportunity by subtype
      • Table Market opportunity by subtype
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global peripheral neuropathy treatment market by geography - Market share 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Americas - Market size and forecast 2017-2022 ($ mn)
      • Table Americas - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table EMEA - Market size and forecast 2017-2022 ($ mn)
      • Table EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table APAC - Market size and forecast 2017-2022 ($ mn)
      • Table APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Companies contributing to the development of late-stage therapeutics for peripheral neuropathy
      • Table Recent drug approvals for the treatment of peripheral neuropathy
    • Market challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Eli Lilly
      • Table Eli Lilly: Overview
      • Table Eli Lilly - Business segments
      • Table Eli Lilly - Organizational developments
      • Table Eli Lilly - Geographic focus
      • Table Eli Lilly - Segment focus
      • Table Eli Lilly - Key offerings
      • Table Eli Lilly - Key customers
    • Johnson & Johnson
      • Table Johnson & Johnson: Overview
      • Table Johnson & Johnson Services - Business segments
      • Table Johnson & Johnson - Organizational developments
      • Table Johnson & Johnson - Geographic focus
      • Table Johnson & Johnson - Segment focus
      • Table Johnson & Johnson - Key offerings
      • Table Johnson & Johnson - Key customers
    • Novartis
      • Table Novartis: Overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
      • Table Novartis - Key customers
    • Pfizer
      • Table Pfizer: Overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
      • Table Pfizer - Key customers
    • TEVA Pharmaceutical Industries
      • Table TEVA Pharmaceutical Industries: Overview
      • Table TEVA Pharmaceutical Industries - Business segments
      • Table TEVA Pharmaceutical Industries - Organizational developments
      • Table TEVA Pharmaceutical Industries - Geographic focus
      • Table TEVA Pharmaceutical Industries - Segment focus
      • Table TEVA Pharmaceutical Industries - Key offerings
      • Table TEVA Pharmaceutical Industries - Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report